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ABSTRACT 
Introduction and objective 
Pulmonary tuberculosis poses a major public health threat. Reports indicating a higher 
morbidity with surgery in active disease have resulted in a reluctance to operate. This study 
examines the results of lung resection in two groups of patients, one with active pulmonary 
tuberculosis, defined on microbiological and pathological grounds, and the second with 
sequelar disease. The hypothesis that surgery should be avoided in patients with active 
disease, in view of the perceived increased risk of complications, is tested. 
Materials and methods 
A retrospective review of the outcomes for patients operated on for active and sequeJar 
tuberculosis was undertaken. One hundred and sixty three patients underwent anatomical 
lung resection for pulmonary tuberculosis between 1998 and 2004. There were 106 patients 
with active tuberculosis (group 1). Disease activity was determined by radiographic, 
microbiological and pathological assessment. The sequelar group (group 2) consisted of 
patients with no evidence of disease activity. 
Indications for surgery included multidrug resistant tuberculosis (group 1 = 27, group 2 = 2), 
haemoptysis (group I = 44, group 2 = 32), bronchiectasis (group 1 = 27, group 2 = 23) and 
diagnostic dilemma in 8 patients in group I. Statistical analysis was performed using SPSS 
11.5® and EpiCalc 2000®. 
Results 
A total of 85 pneumonectomies (group l = 59, group 2 = 26) and 76 lobectomies (group 1 =
47, group 2 = 29) were performed. The overall morbidity was 22.7% (9.4% in the active 
group and 22.8% in the sequelar group). There was no significant difference in morbidity 
4 
between the groups [p = 0.081 RR 0.63 CI 0.36 - 1.11] despite a trend to a higher morbidity 
in the sequelar group. There was also no correlation between the indication for surgery and 
morbidity (p = 0. 719), although patients with sequelar disease and haemoptysis did appear to 
be at risk for complications [p = 0.043, RR 1.61, CI 1.06- 2.45]. The incidence of 
bronchopleural fistulae was 0.9% in group 1 and 1.8% in group 2. Post-pneumonectomy 
empyema occurred in 5.7% in group 1 and 5.3% in group 2. There were 3 deaths. HIV status 
did impact on overall morbidity [p = 0.041, RR 1.88, CI 1.05 - 3.36] despite the small 
numbers. There was no correlation between complications and HIV status in the individual 
groups. 
Conclusion 
Specific management guidelines cannot be advocated in view of the limited number of 
patients in this study; however there are trends that should be noted. 
Surgery may be undertaken in the face of active disease with results comparable to sequelar 
disease, this is emphasised by the results in the challenging MDR group. Haemoptysis, often 
requiring surgery in the acute setting, may also be managed in the setting of disease activity 
with the understanding that surgical results are comparable to that of sequelar disease. In 
addition to this, it is suggested that further study is required on the impact of HIV on 
thoracic surgical interventions. 
Introduction 
1.1 History 
The surgical discipline of Thoracic Surgery owes much of its early development to 
Mycobacterium tuberculosis. (MTB) On review, there are three periods over which the 
surgical management of tuberculosis has evolved 
1
• 
The first period extended from the eighteenth to the early nineteenth century when drainage 
of tuberculous cavities was first reported in 1726. In 1844, Hastings and Stork opened a 
cavity through the chest wall with success. Further efforts met with limited success and 
surgery fell out of favour. Koch isolated the tubercle bacillus in 1882, helping facilitate the 
development of appropriate drug therapy 
1•2• 
The surgical armamentarium expanded in the second half of the nineteenth century and the 
early twentieth century with the introduction of "collapse therapy" using a therapeutic 
pneumothorax pioneered by Forlanini. This procedure aimed to collapse the infected lung, 
allowing the lung to "rest", thereby facilitating healing. It was also believed that disease 
spread to uninvolved lung would be limited. Surgical options to achieve collapse included 
phrenicectomy, extrapleural plombage with insertion of foreign material such as methyl­
methacralate balls, thoracoplasty and the creation of an artificial pneumothorax. Alternatives 
included apical pleural adhesiolysis via thoracoscopy. 
The limitations of thoracotomy with thoracoplasty were cosmetic and functional with 
impairment of limb girdle movement. There was a concomitant increase in the popularity of 
sanatoria for isolation of patients with tuberculosis 
The first limited resection was undertaken by Tuffier in 1891 1•2 • Pulmonary resection was
undertaken reluctantly in view of the high morbidity. It was during this period, in 1895, that 
radiographic evaluation became available helping define the pathology and disease extent, 
and in planning surgical intervention. 
The latter half of twentieth century saw a surge in the number of pulmonary resections for 
tuberculosis being undertaken. This coincided with the development of effective 
chemotherapeutic options in the 1960' s, prior to which, patients had little chance of cure and 
were confined to sanatoria in the hope of healing themselves. 
The first lobectomy was attributed to Freedlander in 1935 1. Surgical resection became more
attractive as a management strategy with further improvements in anaesthetic and surgical 
technique producing better results. The key principles were optimal pre-operative 
preparation including nutritional supplementation and physiotherapy. 
The success of medical therapy, with effective cure rates of over 90%, resulted in surgery 
being relegated to limited indications ie. Haemoptysis and the management of complications 
post treatment. Medical success was short-lived as patient non-compliance over the 
prolonged treatment period, the emergence of the Human Immunodeficiency Virus (HIV) 
and the persistence of social issues i.e. malnutrition, poverty and overcrowding, surrounding 
the disease led to the emergence of multi-drug resistant tuberculosis (MDR TB), defined as 
resistance to at least rifampicin and isoniazid 3•4•5. 
MDR TB has helped redefine the role of surgery for tuberculosis as a valuable adjunct with 






Mycobacterium tuberculosis is one of more than 30 members of the genus Mycobacterium. It 
is a facultative aerobic, acid-fast bacillus transmitted via the respiratory route. The presence 
of the organism produces an infection with or without clinically significant disease 
dependant largely on the immune response generated. 
Inhalation of the organisms is followed by macrophage phagocytosis. The organism may 
then be destroyed or continue multiplying. Multiplication results in the destruction of the 
macrophage and release of a large number of the bacilli. This bacteraemia may result in no 
symptoms or produce a "flu-like" illness. 
The bacteraemia continues for 2-10 weeks until a cell mediated immune response and a 
delayed hypersensitivity reaction limit multiplication and allows healing. 
This hypersensitivity reaction produces caseous necrosis and granuloma formation, which in 
turn, may produce fibrosis resulting in lung damage. 
The disease may progress primarily or remain quiescent with later reactivation. The usual 
risk of disease progression is 5-10% in the patient's lifetime, co-infection with HIV increases 
this to 5-10% per year 6•7 .
Progressive pulmonary tuberculosis, in unsensitized patients, may present as an acute 
bacterial pneumonia with consolidation distributed mainly in the lower and middle lobes. 
This distribution is determined by the airborne transmission of the organism. Hilar 
lymphadenopathy and pleural effusions may also occur. 
In patients sensitized to the organism, disease reactivation results in a distribution that 
favours the apex of the upper lobe and the superior segment of the lower lobe as a result of 
the increased oxygen tension and reduced lymphatic drainage in these regions. The tissue 
response to reactivation disease produces fibrosis that walls of the focus and cavitation. 
Lymphadenopathy is generally uncommon 7. 
The cavities that form may be colonized by either fungal elements eg. Aspergillus fumigatus, 
producing aspergillomas, or bacterial organisms. Persistence of the cavities despite medical 
"cure" may occur resulting in significant haemoptysis requiring emergency surgery. The 
haemoptysis may be related to an aspergilloma, erosion of a pulmonary artery branch 
traversing the cavity, rupture of a Rasmussen aneurysm or bronchial artery erosion. 
Miliary disease may also involve the lung when a collection of the bacilli enters the blood 
stream or the lymphatic vessels. 
1.3 Overview and literature review 
Pulmonary tuberculosis poses a major threat to public health in South Africa. It has been 
reported that there is one TB related death every 40 minutes with 180 000 new cases 
annually, two thousand of which are MOR TB, co-infection with HIV in 60% of adults 
having dormant TB infections 8·
9
. 
Worldwide, there is a new tuberculosis infection every second with one third of the world's 
population being infected with the bacillus. In keeping with this, Furak reported that surgical 
intervention for TB has been increasing annually as well by 5-6% 10. 
II 
The indications for surgery in pulmonary tuberculosis include 1•2•3 ·5: 
i) multi-drug resistant tuberculosis
ii) complications of tuberculosis, including haemoptysis and bronchiectasis
iii) complications of surgical treatment including post-resectional infections
iv) diagnostic dilemma where tumour cannot be excluded
The key issue in planning surgery is the control of disease activity prior to intervention in an 
effort to reduce complications 11. Active tuberculosis, indicated by sputum smear positivity
or a positive histology demonstrating acid fast bacilli and/or necrotizing granulomatous 
inflammation, has been considered a relative contraindication to surgery 
11• 12
.
The reasons behind the avoidance of surgery in the presence of disease activity are based on 
the historically reported morbidity. Mouroux reported a morbidity of 12.5% and mortality of 
5.5% in a group of 11 patients with active disease 
13. Reed and Rizzi have reported




• Furak reported a morbidity rate of
22.9% in patients with active disease with an overall morbidity of 45.8% 10. Morbidity rates
of 30% in MDR patients who were sputum positive have also been reported 3. 
Surgical resection, limited to non-anatomical wedge resection and lobectomy, for active 
tuberculosis results in a morbidity of 14% 12. The overall cure rate for these patients is 
64.8%. 
It is evident that lung resection for inflammatory lung disease is not considered an innocuous 
procedure 10·13• 16·17· 1 8• 19. The technical complications as well as anticipated post-operative
complications including bleeding, air leaks, post-pneumonectomy empyemas (PPE) and 
bronchopleural fistulae (BPF) have prompted Reed to suggest that surgery be avoided in 
these patients 15• 
10 
In consideration of the above-mentioned facts, patients are managed medically, if possible, 
until sputum negative and then operated on electively. 
The minimum duration of medical therapy prior to surgical intervention is dependant on the 
indications for surgery. 
Iseman, supported by Pomerantz, has concluded that a minimum of 3 months of appropriate 
therapy is required in the MOR group 3. Patients with the sequelar forms of the disease are 
managed with a full course of anti-tuberculous therapy prior to surgery. 
The primary indications for surgery in active disease include MDR TB, where surgery is 
considered for persistent sputum positivity, and in those presenting with massive 
haemoptysis where surgery is undertaken emergently. 
1.3.1 MOR TB 
Surgery for MOR TB is recognized as a valuable adjunct to the medical therapy of these 
patients in retrospective studies 3•20·21. There are currently no prospective trials comparing
medical therapy alone against surgery combined with medical therapy. 
Medical therapy alone is disappointing with reported cure rates of 50%, of greater concern is 
that 50% of these patients will develop disease recurrence 3•
Surgery is offered mainly for failure of medical therapy. It is believed that the fibrous tissue 
around cavities forms a "firewall" protecting the organism from the drugs. Cavities have 
been shown to house 107 - 109 organisms and removal of this tissue allows for better drug 
I' 
tissue penetration 20• Nodules also harbour significant numbers of the organisms and should
ideally not be left behind in surgery for MDR TB.
Surgery is offered after a minimum of 3 months of appropriate culture directed therapy. 
Goble showed that sputum conversion was usually achieved between 1 to 8 months of 
medical therapy with a median of 2 months 
3. Pomerantz added that surgery might be
undertaken following 2 months of treatment in patients with high profile drug resistance 26.
The indications for surgery include localised disease in persistently sputum positive patients, 
disease recurrence and high profile drug resistance to at-least 4 drugs. Patients with bilateral 
disease were originally excluded from surgery. Sung 21 and Shiraishi 27et al have reported the
use of surgery in patients with bilateral disease, with good results, where the disease left 
behind was in the form of nodules, minor cavities or fibrosis. The proviso however is that 
the contra lateral disease must be parenchymal and amenable to medical therapy or localized 
enough to facilitate later surgery should cure not be achieved. Takeda 
23 
also undertook
staged bilateral resections on the condition that the patient's pulmonary function was 
adequate. 
Surgery is associated with complication rates of 17.4% - 30% 
20-27_ 
It is largely because of 
experience in this group of patients that the use of a muscle flap for bronchial reinforcement 
has been advocated to prevent the development of a BPF. 
Pomerantz advocated the use of muscle flaps in the following circumstances: 
1. sputum positivity pre-operatively
2. the presence of a BPF prior to surgery
3. polymicrobial space contamination
4. anticipated space problems following lobectomy
A further risk factor is the presence of endobronchial tuberculosis 5•
The current literature does not support the theory that all sputum positive patients with MDR 
TB require muscle flap reinforcement of the bronchial stump. 
20 • ?? 23 ?4 27 
Van Leuven , Naidoo--, Sung , Park - and Takeda have reported studies where muscle 
flaps were not routinely used, even in sputum positive patients. 
The incidence of bronchopleural fistulae in these reports ranges from O - 6% 20,22·24,27 _ This 
is encouraging when one considers that original reports documented an incidence of 30% in 
. . . 3 sputum positive patients . 
The reduction in this complication is difficult to explain, as there are differences in surgical 
technique in the new reports with variations in the technique of bronchial stump closure. 
There are no comparative trials looking at suture versus staple closure in this cohort of 
patients. In our unit, stapling devices are not used due to financial constraints. It is not 
considered a superior technique. 
In the local experience, surgery is associated with cure rates of over 90% with acceptable 
morbidity (17.4%) and no mortality 
22
.
The current feeling is that a more aggressive strategy involving earlier surgery should be 
.d d 21 22 ?3 Th . .d f . l . . h b . . . h h cons1 ere · ·- . e mc1 ence o surg1ca mtervent1on as een mcreasmg wit t e current 
recourse to surgery being around 83% 25. The earlier use of surgery, combined with 
appropriate medical therapy, is based on the high cure rates achieved. This may avoid a 
progression to extensive bilateral disease precluding surgery
. 
Disease-free survival of more than 80% after 36 months has been demonstrated 20• 
The duration of post-operative treatment varies. Eighteen months of appropriate treatment is 
generally used following radical resection and 24months if residual infiltrative lesions are 
present. Van Leuven 20 suggested an approach regarding the duration of drug therapy
dependant on surgical resection and sensitivities. 
Operations undertaken for MOR TB have supported the theory that surgery may be 
undertaken in patients with active disease, as most of these patients are sputum positive 
disease at the time of surgery. The results in this group of patients support the hypothesis of 
this study. 
1.3.2 Haemoptysis 
Ten to fifteen percent of patients with tuberculosis develop life-threatening haemoptysis 28.
The difficulty in the management of these patients is that they may present as an emergency 
with or without previous TB therapy. 
Minor haemoptysis may be managed conservatively with patients being allowed to complete 
a course of anti tuberculous medication prior to consideration for surgery. 
Massive haemoptysis, defined as a single bout of more than 250ml or at least 600ml over 24 
hours, is associated with a mortality of between 30-50% with medical therapy alone 28. With 
this concern, definitive management at the time of admission is essential, including surgery 
if suitable. 28•29•30 . 
The risk of recurrent bleeding once stabilized is as high as 36.4% with a mortality of 45% of 
these patients dying from asphyxiation or haemorrhage 28. The main cause of death is 
hypoxia and asphyxiation compounded by pre-existing pulmonary disease. 
Knott-Craig 28, Conlan 29and Blyth 30have described the management of this condition from
a South African perspective. The initial strategy includes stabilization and medical therapy 
consisting of intravenous antibiotics, antituberculous therapy and opioid sedation. [Figure. I] 
Detailed evaluation of disease extent is determined with high-resolution computerized 
tomography (HRCT) scan of the thorax 31. General clinical condition and effort tolerance are 
then used to assess patient suitability for resection. 
The commonest source of bleeding is the systemic bronchial artery. In view of this, our 
current protocol includes bronchial artery embolisation for patients not suitable for lung 
resection [Figure. 2 and 3]. This strategy is also adopted as a temporizing measure for 
patients where active disease is present. Success rates of 85% in the short term have been 
reported with a drop to 58% in the long term 32. Ice-cold saline lavage has also been used as 
a temporizing measure in both surgical and non-surgical patients. As such, it allows surgery 
to be undertaken electively with a reduced operative mortality 33•
The reluctance to offer surgery in these patients is based on the presence of active disease, 
the inevitable poor pulmonary reserve due to spill over of blood into contra lateral normal 
lung and the difficulty in bronchoscopically localizing the source of the bleeding in some 
patients. 
Early elective surgery in this group, with a mortality of 7%, is preferred to emergency 
surgery with mortality rates of 22 - 42.9% 28•29•30_
The dilemma is the timing of surgery. Knott-Craig 29 has advocated a brief period of medical 
stabilization of around 5 - 10 days prior to surgery. Delaying surgery may increase the risk 
of recurrent bleeding and increase mortality whereas surgery prior to stabilization may also 
result in significant mortality and morbidity. 
The question also arises as to whether surgery in the face of relatively untreated active 
disease is advisable. If so, surgery could be offered to patients early after admission and 
medical stabilization. 
1.3.3 Diagnostic dilemma 
Tuberculosis has been known to mimic bronchial carcinoma and in this situation, the latter 
must be excluded [Figure. 4). The suspicion of a tumour has been shown to be an indication 
for surgery in 77% of cases where tuberculosis was subsequently proven 
34
• In situations
where a malignancy is difficult to exclude, patients are usually treated for tuberculosis for a 
trial period (6 weeks) and the response, or lack thereof, noted. 
The cause for concern in this group is that lung cancer has been shown to be associated with 
TB in 33% of cases, although this has not been borne out locally 22. 
Ishida 
34 
showed that 66% of tuberculomas have the radiographic criteria for malignancy
thus making tissue diagnosis mandatory. 
The diagnostic strategy includes the submission of sputum for cytology and microbiology, 
bronchoalveolar lavage specimens and fine needle aspiration biopsy, either via the 
transthoracic route or through a fibreoptic bronchoscope 35. This procedure has a diagnostic
yield of over 90% for malignancy and approximately 12% for a specific benign diagnosis, 
thus limiting its value for the latter 36.
It is clear that a negative result for malignancy does not exclude a tumour unless a specific 
benign diagnosis is established. This leads to the next line of invasive investigations for 
tissue diagnosis either via video assisted thorascopy (VATS) or open thoracotomy with the 
aid of frozen section. 
Furak 10 explored 34% of patients where tuberculosis was eventual I y diagnosed and Rizzi 14 
operated on 24.2% of patients with diagnostic dilemma. Extensive pulmonary resection is 
rarely required although Keagy 35 reported on 9 patients where pneumonectomy was 
necessary to exclude malignancy. In this study, major pulmonary resections were performed 
in 24% of patients without confirmation of a bronchial carcinoma. The reasons for this 
included the central location of the mass and its proximity to blood vessels. It must be noted 
that it is not ideal to undertake major resection with only a suspicion of bronchial carcinoma 
in view of a mortality rate of 11.4% for pneumonectomy and a more reasonable rate of 
2.05% for lobectomy 35.
1.3.4 Bronchiectasis 
The rationale for lung resection in patients with the so-called destroyed lung is to: 
a. reduce complications such as haemoptysis
b. improve patient quality of life by reducing recurrent infections
c. remove any organisms present and the lung that harbours them 37 
Surgery is generally undertaken in these patients following a course of anti-TB medication. 
The anatomical extent of the disease is documented radiographically by means of HRCT and 
surgery is planned once active infective processes have resolved. 
1.3.5. Morbidity 
Surgery for active tuberculosis has been reported as part of larger series looking at surgery 
for inflammatory lung disease 37. The consensus is that surgery in these patients is not an 
innocuous procedure and should be avoided because of the prohibitive morbidity and 
mortality. The complications causing the most concern include bronchopleural fistulae 
(BPF) and post-pneumonectomy empyema (PPE). 
1.3.5.1. Bronchopleural fistulae 
Bronchopleural fistulae may : 
1. indicate technical deficiencies in bronchial stump closure
2. be a precursor to or indicate the presence of intrapleural sepsis
3. require surgical re-intervention that may include a mutilating thoracoplasty
The incidence of this complication varies in the literature from 4 - 32%. Pomerantz has 
reported the higher incidence in sputum positive patients with MOR TB 3• 
There have been numerous reports attempting to determine the risk factors for the 
development of a BPF. Tae IGm 4 reported that old age and sputum positivity were risks on 
univariate and multivariate analysis with a low pre-operative forced expired volume in 1 
second (FEY 1) increasing the risk on multivariate analysis. Endobronchial TB at the stump 
has also been found to be a risk factor for the development of this complication. 
The technical issues relating to the prevention of this complication have been dealt with in 
the literature and include: 
1. meticulous suture technique incorporating a ten�ion free suture line
2. preservation of the vascular supply by minimising bronchial stump
skeletonisation and devascularisation.
Deschamps 38 has also evaluated stapling devices in a study including patients undergoing
surgery for malignancy. The BPF risk was higher with hand sutured bronchial closure, 
benign inflammatory lung disease, right-sided resections and low pre-operative FEY 1. 
The traditional method of closing the bronchial stump involves interrupted non-absorbable 
sutures. Pomerantz 5 found that there was no difference in the incidence of bronchial stump 
disruption with either staple or suture closure. Blyth 34 demonstrated a BPF rate of 1.9%
using the hand-sewn technique with either absorbable or non-absorbable sutures, comparable 
with alternative strategies. Vicryl ® (Johnson & Johnson) has been recommended as the 
current suture material of choice for bronchial stump closure by Shields 36.
Reinforcing the bronchial stump with a muscle flap, be it intercostal muscle or lattisimus 
dorsi, has also been advocated, mainly in the MDR patient. Massard 16 advocated the routine
use of this technique after reporting a 12% incidence of bronchopleural fistulae and 32% risk 
of postpneumonectomy empyema with no muscle flap reinforcement. Sputum positivity and 
the presence of endobronchial TB are said to warrant this intervention, however local 
experience with MDR TB does not support the routine use of the muscle flap22.
1.3.5.2. Post-pneumonectomy empyema 
The post-pneumonectomy empyema occurs in 13-45% of cases and has significant 
implications for surgeon and patient 37. It commits the patient to a prolonged period of
drainage and sterilisation of the pleural space and may require further surgical intervention 
for definitive management, either in the form of open drainage or thoracomyoplasty. 
It occurs more commonly on the left and the so-called left bronchus syndrome coined by 
Ashour 39 attempts to offer an explanation. It is believed that the more horizontal plane of the
left main bronchus, the decreased peribronchial space and the fact that the bronchus is 15% 
narrower than the right main bronchus all contribute to the increased incidence of left sided 
disease. It is for this reason that a left pneumonectomy is the commonest resection 
performed. The other risk factors include: 
1. polymicrobial space contamination during surgery
2. resection through an empyema 37•
42 
3. active disease
4. violation of parenchymal cavities
5. increased intra-operative blood loss
6. re-opening for bleeding
7. increased patient age
8. low pre-operative FEY 1,
which increase the incidence of post-pneumonectomy empyema 6•32 • Blyth reported a 22%
incidence of this complication in a cohort of patients with active disease 35. 
1.3.6 HIV 
A confounding variable that has not been addressed in the literature is the impact of HIV on 
the surgical management of patients with TB. There are no large reports dealing with this 
issue and it is hoped that this review will highlight the need for more research. The 
importance of the CD 4 count lies in the postulate that the level may correlate with outcome 
following surgery. 
Notwithstanding the worldwide distribution of pulmonary tuberculosis, to date there are no 
large reports on anatomical pulmonary resection in patients with active disease and HIV. The 
anxiety about surgical intervention in older reports regarding surgery for TB must be viewed 
with circumspection, as advances in both surgical and anaesthetic technique must be 
considered. 
1.4 Aims and hypothesis 
1.4.1 Aims 
1. Determine if lung resection for pulmonary tuberculosis could be undertaken in
patients with active disease with results in keeping with or better than reports in the
literature.
2. Compare the results in the active group, in a descriptive study, with a similar cohort
of patients with sequelar pulmonary tuberculosis to determine if the morbidity and
mortality were equivalent.
1.4.2 Definitions 
1. Active pulmonary tuberculosis was defined by the presence of
a. Post-operative histology and microbiology results where active tuberculosis
was demonstrated by the presence of caseating, necrotizing granulomatous
inflammation with or without acid-fast bacilli.
b. Any of the following
1. History of inflammatory lung disease
11. Positive pre-operative sputum culture result if available
111. Chest radiographic and HRCT features of active pulmonary
tuberculosis ie. nodules, interstitial infiltrates, mediastinal
lymphadenopathy with central breakdown
2. Sequelar disease was defined by the presence of
a. Post-operative histology with no caseous granulomatous inflammation. The
presence of fibrosis and necrotizing granulomatous inflammation alone was
discussed with the pathologists and was used to indicate sequelar disease.
) ' 
b. Any of the following
1. History of inflammatory lung disease
11. Negative sputum culture results pre-operatively were not always
available. If this was the case, the other defining factors were used in
distinguishing sequelar disease.
111. Radiographic features suggesting old/burnt out disease
1.4.3 Objectives 
1. Identify sequential patients, with inflammatory lung disease, with similar clinical
presenting features.
2. Separate these patients into cohorts based on the presence or absence of active
tuberculosis.
3. Evaluate the cohorts in terms of the pre-operative treatment, indications for surgery,
surgical intervention and post-operative complications including
i) post resectional empyema
ii) bronchopleural fistula
iii) prolonged air leak
iv) persistent space problems
v) bleeding
4. Identify factors that may contribute to the morbidity following surgery i.e.
i) the presence of HIV co-infection
ii) indications for surgery
iii) duration of pre-operative treatment
iv) histological disease activity
5. Evaluate the follow-up looking for differences between the active and sequelar
cohorts.
The hypothesis that surgery may be undertaken in patients with active tuberculosis with a 
morbidity and mortality equivalent to a similar cohort with sequelar disease was tested. 
2. Materials and methods
A clinical retrospective analytical non-randomised cohort study was undertaken to review all 
lung resections for inflammatory lung disease in our unit over a 7year period from 1998 to 
2004. 
Records of sequential patients from the Department of Cardiothoracic Surgery at Wentworth 
Hospital and subsequently at Inkosi Albert Luthuli Central Hospital as well as King George 
V hospital were reviewed. Ethical approval was obtained from the Faculty of Medicine 
Ethics Committee at the University Of Kwa-Zulu Natal. 
Patient inclusion was dependant on the following: 
1. Active and sequelar tuberculosis as previously defined
2. Medical history of previous or current therapy for tuberculosis in the sequelar group
3. Anti-tuberculous therapy was not a prerequisite for inclusion in the active group
4. Suitability for pulmonary resection based on general condition and radiographic disease
distribution
5. Anatomical pulmonary resection with the minimum being a lobectomy
6. Patients were excluded if pre-operative testing confirmed the presence of malignant lung
disease
Patient evaluation included the documentation of demographic data with a detailed review of 
the past medical history. Suitability for pulmonary resection was based partially on the New 
York Heart Association disability grading system. In addition to this, pulmonary function 
testing was undertaken, excepting those patients presenting with massive haemoptysis where 
it was felt that this might precipitate bleeding. Resting arterial blood gases were obtained in 
this situation. 
Plain chest radiographs and HRCT were undertaken to assess the anatomical extent of the 
disease and plan surgery. Plain chest radiographs tended to underestimate the disease extent. 
HRCT has been reported to be effective in diagnosing tuberculosis in up to 91 % of cases 32.
Extensive bilateral disease precluded surgery. Resection was considered in patients with 
localized bilateral disease that were amenable to staged resections, mainly in the MDR 
group. Localization of the source of bleeding in patients with bilateral disease dictated the 
site of resection. 
Testing for HIV was undertaken with informed consent. There was no access to 
antiretroviral medication during this review and it was the Cardiothoracic Surgery unit 
policy not to operate electively on HIV positive patients with a CD4 count less than 
400cells/mm3. In those found to be HIV positive, CD4 counts were determined prior to
surgery unless the procedure was undertaken as an emergency. Emergency surgery was 
undertaken independent of the test. 
Informed consent for lung resection was obtained in all patients. 
The indications for resection included the following: 
2.1 Multi-drug resistant tuberculosis (MDR TB) 
a. This was defined as resistance to at-least rifampicin and isoniazid.
b. Surgery in this group was only undertaken after a minimum of 3 months of 
therapy guided by sputum culture and sensitivity results. There were no
standardized protocols for the medical therapy which included at least 3 new 
drugs, of which 2 were bacteriocidal. Regimen, arc variable and not
standardized, many including 4-5 oral drugs combined with an 
aminoglycoside and/ or capreomycin continued for a period of 6-24 months. 
The exact strategy was determined by resistance patterns, local experience 
and physician choice. Drugs were administered daily or 5 times weekly. A 
flouroquinolone was included in all patients. 
c. Indications for surgery included localised disease in persistently sputum
positive patients, disease recurrence and high profile drug resistance to at­
least 4 drugs.
d. Patients were subsequently followed up at the MDR clinic at King George V
Hospital, receiving an 18 month post-operative course of appropriate drug
therapy
2.2 Bronchiectasis with recurrent infections 
a. Completion of a course of anti-tuberculous therapy, consisting of rifampicin,
isoniazid, pyrazinamide and ethambutol for the initial 2 months followed by
rifamipicin and isoniazid for a further 4 months prior to surgery was essential
b. Admission was followed by rigid bronchoscopy looking for evidence of
active suppuration. Infections were managed by culture directed antibiotics
and physiotherapy
c. Repeat bronchoscopy was undertaken after a period of medical therapy and
surgery was planned only when the acute infection was controlled.
d. In certain circumstances, it was not possible to completely clear the
secretions. Surgery was then performed using bronchial isolation techniques
to minimize contralateral contamination. These will be discussed later.
2.3 Emergencies, exclusively haemoptysis 
a. This group included massive haemoptysis, defined as a single bout of more
than 250ml or a cumulative amount of more than 600ml over 24 hours, a
volume less than the above being regarded as minor.
b. The local strategy for management is illustrated in figure. 1
c. Anti-tuberculous therapy, intravenous broad-spectrum antibiotics and opioid
sedation were part of the initial management of patients with massive
haemoptysis.
d. Minor haemoptysis allowed time for assessment for surgery, which was
performed electively following a minimum of 3 months of anti-tuberculous
therapy.
e. Non-surgical patients were offered bronchial artery embolisation (BAE), an
interventional strategy performed by the radiologists.
f. The unit policy occasionally dictated instillation of ice-cold saline 33 into the
airways as a last resort for patients with non-surgical disease.
g. The presence of extensive bilateral disease on HRCT precluded surgery. 
h. Staged resections were undertaken electively for localized bilateral disease.
2.4 Diagnostic dilemmas 
a. The usual radiographic picture was that of an isolated pulmonary nodule or a
suspicious opacity with non-specific symptoms.
b. Investigations included plain chest radiograph, with comparison to previous
films, HRCT and sputum examination for microbiology and cytology.
c. Bronchoscopy, either by means of a rigid or flexible instrument was
undertaken to obtain further specimens for microbiology and cytology.
d. Failure of the above mentioned tests necessitated transthoracic fine needle
aspiration biopsy.
e. The unit policy was to undertake exploratory thoracotomy where fine needle
aspiration was unhelpful as video-assisted thoracoscopic facilities were not
available. In the early part of this review, the Dept of Anatomical Pathology
was geographically separate from the Cardiothoracic Unit and frozen section
was difficult. In view of this, anatomical resection was performed. It was felt
that it was better to treat the more sinister condition.
f. The current location of our department makes frozen section more accessible
and has eliminated major pulmonary resections for tuberculosis in the case of
a diagnostic dilemma.
2.5 Surgery 
Surgery was performed under general anaesthesia, with the use of epidural analgesia 
dependant on the experience of the anesthetist. When not inserted, intercostal rib blocks 
were used and the post-operative analgesia was provided by parenteral opioids combined 
with non-steroidal anti-inflammatory agents. 
Bronchial isolation was essential to reduce contralateral contamination by secretions. 
Techniques included the use of a double lumen endotracheal tube or bronchus blockers 
(embolectomy catheters or Foley® urinary catheters) in younger patients. In rare instances, 
prone positioning was required as described by Sellars Brown. 
A second-generation cephalosporin (cefuroxime) provided antibiotic prophylaxis with 
surgery being performed under cover of anti-tuberculous medication. 
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Standard posterolateral thoracotomy incisions were used; the dissection was usually within 
the pleural plane. The extrapleural route
28.
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was reserved for localized, densely adherent
areas depending on surgical preference and expertise. This plane was avoided in view of the 
increased risk of bleeding. 
The bronchial stump was managed according to the following principles: 
1. limited dissection, minimal skeletonisation to maintain vascularity
2. interrupted absorbable sutures were commonly used for closure non-absorbable
sutures being dependant on the surgeon's preference
3. stapling devices were never used due to the prohibitive financial cost
4. generally, no attempt was made to use muscle flap reinforcement and the bronchial
stump was kept short to reduce infective complications.
The pleural space was drained by means of a single underwater seal drain following 
pneumonectomy and 2 drains were used for lesser resections. The post-pneumonectomy 
space was drained for 24 hours with the drain being clamped and released intermittently for 
5 minutes every hour. Drainage was continued depending on the residual air leak in the 
patients undergoing lesser resections. 
Ambulation was commenced on day 1 and discharge usually effected within 7 - 10 days if 
complication free. Anti-tuberculous medication was continued for 6 months in all patients 
with active disease except for the MOR group where the post-operative course was over 18 
months. 
The following outcomes were assessed in both groups: 
1. Sputum conversion where pre-operative sputum status was available
2. Development of major complications ie.
1. Bronchopleural fistulae - major airway communication with pleural
space indicated by air leak from the drains and the bronchoscopic
evidence of a fistula
11. Post-resectional empyema - infection in the residual pleural space
defined by the presence of frank pus or culture positive pleural fluid.
This was usually accompanied by the systemic signs of sepsis.
111. Residual space problems - radiographic evidence, plain radiograph
and HRCT, of a space with incomplete re-expansion of the residual
lung. There were no symptoms with this complication. Concomitant
space infections were included in the post-resectional empyema group
iv. Prolonged air leak - drainage for more than 7 days
v. Post-operative bleeding with more than 150ml/hr for more than 3
hours.
3. Mortality
These outcomes were used as they represent the commonest complications following lung 
resection. As mentioned in the introduction, inflammatory lung disease is a risk factor for 
them and surgery for active tuberculosis is suggested to be associated with a higher risk than 
with sequelar disease. 
Follow up was at the Thoracic Clinic and the MDR patients were reviewed at a separate 
clinic run by the physicians. 
2.6 Statistical analysis 
, I 
Statistical analysis was undertaken in consultation with a statistician from the Medical 
Research Council. Patients were separated into groups depending on the presence of active 
disease. The HIV positive group of patients was also analysed. 
It was expected that a statistical difference would be detected between the active and 
sequelar forms of the disease if 377 patients are included in Group 1 and 188 in Group 2, 
provided the difference was as large as 11 %, i.e. 5% morbidity in the Group 2 and 16% in 
Group 1. In the course of collecting the data, it became clear that the numbers were 
insufficient for this purpose and it was suggested that the study concentrate more on clinical 
significance and trends. 
Relative risks and 95% confidence intervals were determined to compare the incidence of 
the morbidity between the exposure groups using EpiCalc 2000, Version 1.02 
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Confounding variables, including Human Immunodeficiency Syndrome (HIV) status, pre­
operative TB therapy and sputum status were controlled for using Poisson regression. The 
statistical analysis was undertaken with SPSS 11.5 ®. Statistical significance was defined by 
a p value < 0.05 
3. Results
One hundred and sixty three patients underwent lung resection. One hundred and six fell into 
the active group (Group 1) and 57 patients had sequelar disease (Group 2). There were 105 
males and 58 females with a mean age of 33.5years (range 2 - 69yrs). The further results 
have been divided into the two groups. 
3.1 Active tuberculosis (n = 106) 
There were 67 males and 39 females in this group, with a mean age of 33.3yrs (range 2 -
69yrs) 
3.1.1 Multi-drug resistant tuberculosis (n = 27) 
The MDR group had all received a minimum of 3 months of appropriate therapy based on 
drug sensitivities. Surgery was offered in this group for localized cavitatory disease (n = 12), 
multiple recurrences (n = 4) and persistent sputum positivity (n = 11). 
Radiographic confirmation of the disease extent was undertaken with HRCT and in 2 
patients with multiple recurrences; there was contralateral limited parenchymal disease. 
The commonest resection was a left pneumonectomy. (Table 1) 
Two patients required re-thoracotomy for bleeding in the immediate post-operative period 
with a further 2 developing post-pneumonectomy empyemas (7.4%). A bronchopleural 
fistula developed in a single patient (3.7%) resulting in an overall major morbidity rate of 
18.5% (Table 3). Minor complications developed in 2 patients, one developing minor skin 
wound sepsis and the second developing a pneumonia managed with oral antibiotics. The 
overall morbidity was 25.9%. 
Six patients in this group were HIV positive, all with CD4 counts over 400cells/mm
3
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In this sub-group, a single patient developed a post-pneumonectomy empyema with the 
wound sepsis and pneumonia occurring in 2 other patients resulting in 50% morbidity. 
Two patients were found to be sputum positive at the end of 18 months of therapy. They had 
been in the group with multiple recurrences and had developed contralateral disease 
precluding further surgery. Surgery produced a cure rate of 92.6%. 
3.1.2 Haemoptysis (n = 44) 
The mean duration of pre-operative anti-TB therapy in the group with haemoptysis was 
43.7days (range of 2days to 6months). Four patients were sputum positive in this group. 
Bronchial artery embolisation was undertaken in 9 patients, including the four patients that 
were sputum positive pre-operatively. This allowed for the "elective" planning of resection 
in 4 patients during the same admission. 
A single patient developed massive haemoptysis following BAE mandating emergent 
surgery. 
The complications included minor wound sepsis in 2 patients, atelectasis of the remaining 
lung in a patient undergoing an upper lobectomy and post-operative pneumonia in a further 2 
patients, one of whom was sputum positive. The overall morbidity rate was 11.4%. There 
was no major morbidity. 
There were 2 patients that demised in the post-operative period resulting in a mortality rate 
of 4.5%. The first patient died on day 3 post-operatively from an unknown cause; his family 
refused consent for a post-mortem to be performed. The second patient was HIV positive; 
his presumptive cause of death was a pulmonary embolus. 
Post-operative therapy was continued for 6 months. Seven patients were HIV positive, with 
CD4 counts ranging from 350 - 666cells/mm3• 
Follow up was achieved in 36 patients over a period ranging from 1 - 8months. (Mean of 
2.lmonths)
3.1.3 Bronchiectasis (n = 27) 
Surgery was indicated in these patients with recurrent chest infections and radiographic 
evidence of bronchiectasis. This included patients with previous empyema where the 
underlying lung was destroyed. 
Five patients were found to be sputum positive on pre-operative assessment and received a 
further 3 months of therapy prior to surgery. 
The resections undertaken are listed in Table 1. Two patients were HIV positive in this group 
with CD4 counts over 400cells/mm3. There were no complications in the HIV positive 
patients. 
Morbidity occurred in 18.5% of patients: 
i) PPE in three patients ( 11. l % ) requiring prolonged drainage with subsequent
sterilization of the pleural space
ii) post-operative pneumonia in a single patient
iii) failure of residual lung re-expansion in a further patient resulting in a persistent
pleural space. This had resolved on follow up.
3.1.4 Diagnostic dilemma (n = 8) 
The evaluation and management of patients where malignancy could not be excluded 
involved a trial of anti-TB therapy. The mean duration of this trial period was 42.5days. 
Pre-operative needle aspiration had been undertaken unsuccessfully in all patients. 
Exploration was based on the radiographic features that favoured malignancy. In one patient, 
in light of the clinical suspicion of malignancy rather than inflammatory lung disease, a 
pneumonectomy was undertaken. This is not the standard practice. In view of the difficulties 
already mentioned regarding the initial availability of frozen section, it was felt that the 
patient was better served by the operation performed. 
It was unfortunate that a PPE developed in this patient with a resultant morbidity rate of 
12.5% (p = 0.563). There was no evidence of a BPF and the PPE was managed by drainage 
and sterilization. There were no operative or early post-operative deaths. 
3.2 Sequelar disease (n = 57) 
There were 38 males and 19 females with a mean age of 3 l.9yrs (range 3 - 6lyrs). 
3.2.1 Multidrug resistant tuberculosis (n = 2) 
There were only 2 patients in this cohort with no complications or mortality. 
3.2.2 Haemoptysis (n = 32) 
Twenty-four of these patients had received treatment prior to surgery over a period ranging 
from 10 to 365days (mean 94.Sdays). Thirteen patients had undergone bronchial artery 
embolisation prior to surgery. 




The following complications occurred: 
i) post pneumonectomy empyema in 2 patients, both of whom had received
treatment prior to surgery in addition to a previous course of medication.
ii) bronchopleural fistula in a single patient requiring prolonged drainage, no
further surgical intervention was required
iii) ventilation in two patients immediately post-operatively following
emergency surgery. They were both extubated within 48hours.
iv) minor wound sepsis in a single patient
v) pneumonia requiring oral antibiotics in a single patient
vi) persistent pleural space in 6 patients which remained, albeit without
symptoms, in 3 patients on follow up
The overall morbidity was 40.6% with a major morbidity rate of 15.6%. There were no 
deaths in this group. The commonest resection was a lobectomy (Table 2). 
3.2.3 Bronchiectasis (n = 23) 
There were nineteen patients in this group that were operated on whilst receiving anti-TB 
medication. The remaining patients had all received a course before admission. There were 2 
patients that were HIV positive. 
The following complications developed: 
i) post pneumonectomy empyema in a single patient (4.3%) that was managed by
open drainage
ii) post-operative pneumonia in one patient
iii) persistent pleural space in a further patient
The morbidity rate was 13%. There was a single death in this group from causes unknown. 
No post-mortem was performed. 
3.3 Analysis 
The overall major morbidity in the study was 13.8%. There was no statistically significant 
difference between the morbidity in the active and sequelar groups (9.4% and 22.8%, p = 
0.081, RR 0.63 with CI 0.36-1.11). The morbidity, somewhat surprisingly, was higher in 
the group with sequelar disease. 
The commonest complication in both groups was that of a post-pneumonectomy empyema 
occurring in 5.7% and 5.3% of patients with active and sequelar disease respectively (p =
0.734, RR 1.25 with CI 0.34 - 4.67). Bronchopleural fistulae occurred in 0.9% of patients in 
group 1 and 1.8% in group 2 (p = 0.067, RR 0.77 with CI 0.19-3.08). 
These results are comparable to the reports in the literature. 
There was no correlation between the indications for surgery and morbidity (p = 0.719). 
This held true for both groups, although the sequelar group of patients with haemoptysis 
experienced more complications ( 40.6% vs. 11.4%) than the active group. This was 
statistically significant (p = 0.02, RR 1.61 with CI 1.06 - 2.45), suggesting an increased risk 
for complications in patients with haemoptysis and sequelar disease. 
There was no significant difference in the age ranges between the active and sequelar groups 
with haemoptysis (33.7yr and 39yr). There were more males in the sequelar group with 
haemoptysis but this did not reach statistical significance (p 0.53). Males were more at risk 
of developing complications though with a RR of 1.83 with CI 0.51 - 6.57. In keeping with 
the urgent nature of the surgical intervention, the active group had received much less anti­
tuberculous therapy than the sequelar group (50.9days and 94.5days). Surgery was 
undertaken as emergency in these patients but there was no difference in the ratio of 
emergency surgery in either active or sequelar group. 
It is possible that the higher number of HIV positive patients in the sequelar group with 
haemoptysis may have had some influence on this result (12/32 vs 7/44). HIV positivity did 
suggest a greater risk for complications in the sequelar group with a RR of 1.94 with CI 0.85 
- 4.43. The numbers in this group, were however to small to allow proper comparison.
Twenty five percent of the sputum positive patients developed complications. This figure is 
obviously limited by the fact that some patients may have undergone surgery as an 
emergency with no pre-operative sputum being submitted. Once again, there was no 
statistical correlation, using Fischer's exact test, between sputum status and the risk of 
complications (p = 0.118, RR 1.79 with CI 0.71 - 4.51), but the trend indicated that sputum 
positivity was a risk for complications in the patients with histologically active disease. The 
obvious limitation is the fact that this study is underpowered. 
There was also no correlation between morbidity and the anatomical extent of the resection 
in either group l (p = 0.850) or 2 (p = 0.451 ). 
Pretreatment with anti-tuberculous drugs was also considered. Only 135 patients had 
received pre-operative treatment. The duration in both groups ranged from O -515 days with 
a mean of 79. ldays. Unfortunately this resulted in a skewed graph as the majority of patients 
had received< 100 days of treatment prior to surgery. (Graph 1) The mean duration of 
treatment was 106.9days in group 2 compared to 58.?days in group 1 (p = 0.024). (Graph 2) 
In the patients with complications, it was interesting to note that the Group 2 patients had 
received twice as much pretreatment (60days vs. 30days) than the Group 1 patients. 
Pretreatment must not be confused with prior anti-TB medication which was defined as any 
previous treatment irrespective of the time period separating it from the surgical 
intervention. In group 1, 23.6% of patients had received prior therapy, compared to 28.1 % in 
group 2. There was no correlation between prior treatment and the risk of developing post­
operative complications in either group. 
3.4 HIV status 
The positive HIV status of 30 patients was also considered in the analysis. The overall 
morbidity in this cohort was 36.7% (Table 4). There were complications in 26.6% of HIV 
positive patients in group I compared to 46.7% in group 2. The morbidity in the HIV 
negative patients in group 1 was 17.6%. 
The addition of being HIV positive did not increase the risk of complications in patients with 
active disease significantly (p = 0.450, RR 1.52 with CI 0.59 - 3.92). The relative risk of 
1.52 suggests that HIV positivity may be a risk for complications in patients with active 
disease. This cannot be stated conclusively as the numbers are inadequate. Within group 2, 
the difference in morbidity, 46.7% in HIV positive patients vs. 23.8% in HIV negative 
patients (p = 0.093, RR 1.96 with CI 0.91 - 4.21) was also not statistically significant. 
HIV status overall was a risk factor for morbidity (p = 0.041, RR 1.88 with CI 1.05 - 3.36). 
HIV positivity increased the risk of complications in all patients operated on by a factor of 
1.88. There was no correlation between HIV status and the risk of developing a PPE or BPF 
(p = 0.893 and p = 0.246 respectively). 
It was not possible to compare patients according to indications for surgery due to the small 
number of HIV positive patients, nor was it possible to correlate morbidity with CD4 count 
in view of the small numbers and the fact that the CD4 count distribution was skewed with 
almost all the counts over 400cell/mm3 (Graph 3). This was expected in view of the unit 
policy. Interestingly, the range of CD4 counts were much greater in patients with 
complications with more people having lower counts (Graph 4). The mean counts were 
similar however. 
Multivariate analysis showed that the only variable that reached statistical significance for 
complications was gender in the sequelar group (Table 5). Males were more at risk for 
developing complications (p = 0.036). 
Follow up remains a problem, it is inferred that our patients are well in view of the fact that 
we are the only Thoracic Surgical service in the province and all our patients are returned if 
they complicate. Follow up was available in 135 patients (94 in group 1 and 41 in group 2). 
The duration of follow up ranged from 1 - l 8months. The mean duration was 2.7months in 
group l and 2.4months in group 2. 
4. Discussion
Thoracic surgery owes much of its development to pulmonary tuberculosis 1•
2
• The original
difficulties reported, with regards to the operative complications have largely been 
eradicated due to developments in both surgical and anaesthetic technique. 
4.1 MDR TB 
Surgical intervention has traditionally followed a full course of appropriate medical therapy. 
Recent work on MDR patients has sparked interest in the possibility of earlier surgery. 
Surgery in this group of patients has been considered earlier and in patients that are sputum 
positive with active disease. The results in this study are comparable with the literature with 
an acceptable morbidity and mortality and a cure rate of over 90% 
2 1•23 . The MDR group
may therefore be considered one of the prototypes for surgical intervention in the face of 
active disease. In terms of the controversies: 
1. Bronchial stump closure with muscle flap reinforcement needs further study
although the available literature and the results from the local experience
suggest that routine reinforcement is not necessary 
20- 25. 
In this review, there
were insufficient patients where the stump was reinforced with muscle to
allow for statistical comparison. Further limitations include the low number
of sputum positive patients together with the absence of endobronchial
tuberculosis, a recognized risk factor 15, which may account for the low BPF
rate.
Pomerantz 5, Van Leuven 20and Shiraishi 21are advocates of routine muscle
reinforcement of the bronchial stump. In a report by Takeda et al 23, 26
sputum positive patients with MDR TB underwent surgery with no muscle
flap reinforcement of the bronchial stump. Their incidence of bronchopleural
fistulae was zero. The BPF rate of 3.7% is reasonable in patients with active 
disease. No statistical correlation could be made to patients with sequelar 
disease in view of the numbers. 
2. It was also not possible to compare suture versus staple closure. The cost limitations
in the local unit prevent this. Further study is required to evaluate these techniques.
The role of surgery as an adjunct to the medical management in MOR TB is now well 
established 3•6• 12• 14 • The results in this study confirm the reports in the literature. The 
management of the bronchial stump without muscle flap reinforcement resulted in a low 
incidence of bronchopleural fistulae in the study groups, although larger numbers are needed 
to draw conclusions. Whilst it is not possible to state conclusively that the method of stump 
closure used in this study was the sole reason for the low complication rate, it is suggestive 
and warrants further investigation. It was not possible to assess other variables such as pre­
operative sputum status in view of the lack of adequate numbers. 
It is the current contention that surgery should be considered earlier in these patients in an 
attempt to eradicate disease activity 24. The rationale is that the disease is controlled prior to 
the development of extensive bilateral disease. 
4.2 Haemoptysis 
Patients with haemoptysis, by virtue of the urgent nature of the intervention, may also 
undergo surgery in the face of active disease. The results in this review, with morbidities of 
11.4% in group 1 and 40.6% in group 2 correlate with reports in the literature of between 30 
- 50% [28]. One must bear in mind however that this was in the setting of emergency
surgery. The trend towards a higher morbidity in the sequelar group is noted; and using the 
Fischer's exact test is significant. 
It is difficult to explain why surgery in patients with sequelar disease and haemoptysis is a 
risk for morbidity. 
Evaluating the patient profile did show that there were more males in the sequelar group 
relative to females (24 males and 8 females). This did not reach statistical significance. 
There was also no correlation with the number of HIV positive patients and the risk of 
complications in the sequelar group. These patients had completed a course of anti-TB 
medication and surgery was generally elective. The fibrotic healing reaction induced by 
medical treatment may make surgery hazardous but not more so than in the active group 
where there would be vascular adhesions induced by the presence of active inflammation. 
Patients in both groups underwent surgery in the emergency setting with no difference 
between groups. There are no reports in the literature comparing surgery for haemoptysis 
between cohorts of patients with active and sequelar disease. 
The results also tend to support the contention that surgery may be undertaken in the face of 
active disease with acceptable results. 
In consideration of the higher operative mortality with emergency surgery for active 
haemoptysis, it is suggested, that semi-elective surgery on a patient rendered stable is a 
reasonable alternative. There was no correlation between surgery for active disease with 
haemoptysis and an increased morbidity in this review. In effect, once patients are admitted 
and stabilized, surgery, if anatomically and physiologically feasible, should be planned on 
the next elective list. This supports the work of Knott-Craig 28 and Conlan 
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. The previous
strategy of delaying surgery in these patients if active disease is suspected needs to be 
revised in view of the results in this review. 
4.3 Morbidity 
The incidence of bronchopleural fistulae and post-resectional space infections in the active 
group, 0.9% and 5.7%, are lower than most of those reported in the literature. 
Comparatively, 1.8% of patients in group 2 developed bronchopleural fistulae and 5.3% 
developed post-resectional infections. Whilst there was no statistical significance between 
the active and sequelar groups, the trend was to a higher morbidity in the sequelar group 
(28.1 % ) than in the active group ( 17% ), despite the longer mean duration of medical 
pretreatment. The absence of a statistical difference was expected to a large extent in view of 
the numbers and the study being underpowered. Once again it is difficult to explain this as 
the opposite was expected. There was no significant difference in either patient profile with 
the only risk in the sequelar group on multivariate analysis being gender with males more at 
risk for complications. 
The low incidence of bronchopleural fistulae is despite the fact, as already mentioned, that 
muscle flap reinforcement of the bronchial stump is not routine. There are limitations that 
preclude one drawing conclusions from this but it does warrant further investigation. 
Stapling devices and sputum results were not available in all patients. The technique of 
interrupted suture bronchial closure, with preservation of the blood supply, is a recognized 
technique that warrants comparative study with other methods, preferably in a prospective 
randomized manner. 
The absence of endobronchial tuberculosis in the resected specimens may also explain the 
low incidence of these complications. 
The key principles in the history of surgery for TB have been the promotion of healing of the 
bronchial stump and the avoidance of pleuropneumonic sepsis 
1•2 . 
4.4 HIV status 
The impact of HIV on Thoracic Surgery has yet to evaluated locally. There were only a 
small number of HIV positive patients in this review with a further major limitation being 
the lack of access to antiretroviral medication. This led to deferment of surgery in patients 
with CD 4 counts under 400cells/mm3• The departmental policy is being re-evaluated as the 
availability of these drugs should allow surgery on patients with lower counts and with easy 
access to antiretrovirals, it will be possible to commence medication prior to surgery, and 
continuing post-operatively. 
It was expected that the HIV status would correlate with increased morbidity, this was true 
overall (p = 0.041) with HIV positive patients being almost twice as likely to develop 
complications compared to HIV negative patients [RR l.96]. In specific groups however, 
there was no correlation with morbidity. Being HIV positive and having active disease was 
not a risk factor for morbidity despite a high relative risk [RR 1.52]. There was also no 
correlation between HIV positivity and the development of either a PPE or BPF. The small 
numbers of HIV positive patients in the subgroups could explain this. The relative risks 
suggest a higher risk of these complications. 
The role of the thoracic surgeon in HIV positive patients has not been fully addressed. To 
date there are no reviews addressing this problem and surgery in these patients is largely 
dictated by the circumstances i.e. emergencies or unusual disease manifestations. 
5. Conclusion
Surgery for tuberculosis has come full circle; originally one of the pillars of patient 
management; to being relegated to adjunctive treatment to medical therapy. Whilst the 
results obtained do not demonstrate statistical significance, trends are evident. 
This study has demonstrated that surgery may be undertaken in the face of active disease 
with acceptable morbidity (9.4% ). The reported range for morbidity in this group is 12.5 -
30% 3 • 10• 13• 14·15• The lack of a statistical difference between the active and sequelar group,
due mainly to the numbers in the study, would suggest that surgery may be undertaken 
effectively. 
Lung resection in selected MDR patients produces high cure rates of over 95% with 
acceptable morbidity and mortality. 
The results, morbidity of 11 .4%, in the patient group with haemoptysis suggest that 
immediate medical stabilization with in-patient surgery is a valid management strategy. 
Urgent surgery may be undertaken rather than submitting patients to further medical therapy 
in order to obtain disease quiescence prior to surgery. 
In additions, this study highlights the need for further research on; 
a. the impact of HIV on thoracic surgery
b. the strategy for management of the bronchial stump in patients with active disease
The key principles to bear in mind, as with any surgical decision include careful patient 
selection and preparation, meticulous surgical technique and appropriate post-operative 
surgical care. 
6. Limitations
The major limitations in the study are; 
1. The study is retrospective from a review of patient records from departmental
archives. Complications other than the major ones were all subjectively reported thus
producing a skewed picture with regards to the minor complications.
2. The numbers in the cohorts are small and thus the study is underpowered limiting
statistical significance and conclusions that one may draw from them. Trends may
however may be determined and the areas of further study may be determined
3. The results in the HIV positive group are also skewed by the lack of access to
antiretroviral results and the departmental policy that precluded elective surgery on
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7. Tables, graphs and figures
RESECTIONS MDRTB Haemoptysis Bronchiectasis Diagnostic 
(n = 27) (n = 44) (n = 27) dilemma (n 
=8) 
Right upper lobectomy 1 9 0 6 
Right lower lobectomy 1 1 0 0 
Right pneumonectomy 6 10 11 1 
Left upper lobectomy 5 8 4 0 
Left lower lobectomy 2 2 1 1 
Left pneumonectomy 11 9 11 0 
Upper and middle 1 3 0 0 
lobectomy 
Middle and lower 0 2 0 0 
lobectomy 
Table 1. Resections distributed according to indications for surgery in the active group 
RESECTIONS MDRTB Haemoptysis Bronchiectasis 
(n = 2) (n = 32) (n = 23) 
Right upper 9 1 
lobectomy 
Right lower 1 0 
lobectomy 
Right 7 6 
pneumonectomy 
Left upper 9 3 
lobectomy 
Left lower 0 1 
lobectomy 
Left 6 7 
pneumonectomy 
Middle lobectomy 0 0 2 
Middle and lower 0 0 2 
lobectomy 
Upper and middle 0 0 1 
lobectomy 
Table 2 .. Resections distributed according to indications for surgery in the sequelar group. 
ACTIVE DISEASE SEQUELAR DISEASE 
(n = 106) (n = 57) 
Bleeding - rethoracotomy 2 0 
Post-pneumonectom y 6 3 
empyema 
Bronchopleural fistula 1 1 
Space complications 1 7 
Ventilation 0 2 
TOTAL 10 (9.4%) 13 (22.8%) 
Table 3. Complications following surgery 
COMPLICATIONS ACTIVE DISEASE SEQUELAR DISEASE 
(n = 2) (n = 5) 
Bronchopleural fistulae 1 0 
Post-pneumonectom y 1 1 
empyema 
Space problems 0 2 
Ventilation 0 2 
frable 4. Morbidity in the HIV positive patients correlated with disease activit� 
ACTIVE DISEASE SEQUELAR DISEASE 
p value p value 
Age .09 .283 
Sputum positivity .582 .703 
Indication for surgery .670 .408 
Lung resection .948 .531 
HIV status .075 .273 
Gender .321 .036 
Statistical significance with p < 0.05 
Table 5. Multivariate analysis of risk factors for major complications. 













Std. Dev = 89.04 
I\Aean = 58. 7 
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JGraph 4. Distribution of CD4 counts in all patients with complication� 
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CLINICAL, CXR, HRCT 
I 
NON SURGICAL SURGICAL 
I 
MEDICAL AND BAE BAE IN PREPARATION 
FOR SURGERY 
RESECT 
Figure 1. Algorithm for management of patients with haemoptysis (adopted from 
Blyth 30) 
BAE - Bronchial artery embolisation 
Figure 2. Injection into pathological right bronchial artery demonstrating abnormal 
vessels with neovascularisation 
Figure 3. Post bronchial artery embolisation demonstrating no filling of the 
abnormal vessels 
Figure 4. Chest radiograph demonstrating an opacity in the left upper lobe where a 
malignancy could not be excluded, histology demonstrated caseous 
necrosis consistent with tuberculosis. 
8. Appendix
1. MTB - mycobacterium tuberculosis
2. HIV - Human Immunodeficiency Virus
3. MDR TB - multi-drug resistant tuberculosis
4. TB - tuberculosis
5. PPE- post-pneumonectomy empyema
6. BPF - bronchopleura1 fistula
7. VA TS - video-assisted thoracoscopic surgery
8. FEV 1 - forced expiratory velocity in one second
9. HRCT - high resolution computerised tomography
10. CD4 - cluster of differentiation 4
